União Europeia - grego - EMA (European Medicines Agency)

albireo - odevixibat - cholestasis, intrahepatic - Χολική και ηπατική θεραπεία - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 και 5.

União Europeia - grego - EMA (European Medicines Agency)

sanofi b.v. - avalglucosidase alfa - Τύπος ΙΙ της νόσου αποθήκευσης γλυκογόνου - Άλλα προϊόντα πεπτικής οδού και μεταβολισμού, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

União Europeia - grego - EMA (European Medicines Agency)

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - Άλλα προϊόντα πεπτικής οδού και μεταβολισμού, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

União Europeia - grego - EMA (European Medicines Agency)

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - Εμβόλια - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 και 5. 1 in product information document). Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

União Europeia - grego - EMA (European Medicines Agency)

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - Ανοσοκατασταλτικά - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

União Europeia - grego - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - Άνοσοι οροί και ανοσοσφαιρίνες, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.

União Europeia - grego - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Άλλα φάρμακα του νευρικού συστήματος - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

União Europeia - grego - EMA (European Medicines Agency)

csl behring gmbh - etranacogene dezaparvovec - Αιμορροφιλία Β - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.